Active ingredient
Insulin glargine NDC Codes
Insulin glargine is an active ingredient in 23 finished products listed with the FDA, under 13 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Insulin Glargine, Lantus Solostar, Semglee, Rezvoglar Kwikpen, Toujeo, TOUJEO Max, Lantus, Langlara, Insulin glargine U-300 Max, Insulin glargine U-300, Soliqua 100/33, BASAGLAR KwikPen, Insulin 1556
- Labelers
- A-S Medication Solutions, Biocon Biologics Inc., Sanofi-Aventis U.S. LLC, Civica, Inc., Sanofi-Aventis U.S. LLC, Eli Lilly and Company, sanofi-aventis U.S. LLC, Lanexa Biologics, LLC, Professional Complementary Health Formulas
- Strengths
- Insulin glargine 100 [iU]/mL; Insulin glargine 300 U/mL; Insulin glargine 300 [iU]/mL; Insulin glargine 100 U/mL; Lixisenatide 33 ug/mL; Insulin glargine 9 [hp_X]/29.5mL
- Dosage forms
- Injection, Solution, Liquid
- Routes
- Subcutaneous, Oral
- Drug classes (FDA established)
- Insulin Analog, GLP-1 Receptor Agonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 32
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Langlarainsulin glargine-aldy | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Lanexa Biologics, LLC | 87682-090 | 87682-0090-05 | — |
| Insulin Glargineinsulin glargine-yfgn | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Civica, Inc. | 72572-422 | 72572-0422-0172572-0422-05 | — |
| Insulin Glargineinsulin glargine-yfgn | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Civica, Inc. | 72572-424 | 72572-0424-0172572-0424-05 | — |
| Semgleeinsulin glargine-yfgn | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Biocon Biologics Inc. | 83257-011 | 83257-0011-11 | — |
| Semgleeinsulin glargine-yfgn | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Biocon Biologics Inc. | 83257-012 | 83257-0012-3183257-0012-33 | — |
| Insulin Glargineinsulin glargine-yfgn | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Biocon Biologics Inc. | 83257-014 | 83257-0014-11 | — |
| Insulin Glargineinsulin glargine-yfgn | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Biocon Biologics Inc. | 83257-015 | 83257-0015-3183257-0015-32 | — |
| Insulin glargine U-300 Maxinsulin glargine | Insulin glargine 300 [iU]/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-2900 | 00955-2900-02 | — |
| Insulin glargine U-300insulin glargine | Insulin glargine 300 [iU]/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-3900 | 00955-3900-03 | — |
| Rezvoglar Kwikpeninsulin glargine-aglr | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-6439 | 50090-6439-00 | — |
| Rezvoglar KwikPeninsulin glargine-aglr | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8980 | 00002-8980-05 | — |
| Soliqua 100/33insulin glargine and lixisenatide | Insulin glargine 100 U/mL; Lixisenatide 33 ug/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5761 | 00024-5761-0100024-5761-05 | — |
| BASAGLAR KwikPeninsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7715 | 00002-7715-59 | — |
| Toujeoinsulin glargine | Insulin glargine 300 U/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5869 | 00024-5869-0000024-5869-03 | — |
| TOUJEO Maxinsulin glargine | Insulin glargine 300 U/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-4177 | 50090-4177-00 | — |
| TOUJEO Maxinsulin glargine | Insulin glargine 300 U/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5871 | 00024-5871-0100024-5871-02 | — |
| Toujeoinsulin glargine | Insulin glargine 300 U/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-2193 | 50090-2193-00 | — |
| Lantus Solostarinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-4068 | 50090-4068-00 | — |
| Lantusinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-0876 | 50090-0876-00 | — |
| Lantus Solostarinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | sanofi-aventis U.S. LLC | 0088-2219 | 00088-2219-0000088-2219-05 | — |
| Lantusinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | sanofi-aventis U.S. LLC | 0088-2220 | 00088-2220-3300088-2220-34 | — |
| Lantus Solostarinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-1398 | 50090-1398-00 | — |
| Insulin 1556insulin | Insulin glargine 9 [hp_X]/29.5mL | LiquidOral | Professional Complementary Health Formulas | 63083-1556 | 63083-1556-01 | — |
Insulin glargine: common questions
- Which drugs contain Insulin glargine?
- Insulin Glargine, Lantus Solostar, Semglee, Rezvoglar Kwikpen, Toujeo, TOUJEO Max, Lantus, Langlara, and others listed above.
- Is there a J-code for Insulin glargine?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.